
Bridion is an injection containing the active ingredient sugammadex sodium. It is classified as a modified gamma cyclodextrin, and the injection is designed for intravenous use. Bridion is provided as a sterile, clear solution at a dosage of 100 mg per mL, equivalent to 108.8 mg of sugammadex sodium. The formulation includes a pH adjustment using hydrochloric acid and/or sodium hydroxide, and it may also contain a mono OH-derivative of sugammadex.